Bank of America’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52.9M Buy
936,951
+72,439
+8% +$4.22M ﹤0.01% 1550
2025
Q4
$51.4M Sell
864,512
-85,053
-9% -$4.63M ﹤0.01% 1536
2025
Q3
$51.4M Buy
949,565
+148,094
+18% +$8.47M ﹤0.01% 1743
2025
Q2
$44.1M Buy
801,471
+68,003
+9% +$4M ﹤0.01% 1807
2025
Q1
$51.8M Buy
733,468
+225,643
+44% +$15.2M ﹤0.01% 1549
2024
Q4
$33.4M Sell
507,825
-392,154
-44% -$26.3M ﹤0.01% 1837
2024
Q3
$63.3M Sell
899,979
-123,543
-12% -$10.3M 0.01% 1366
2024
Q2
$84.3M Sell
1,023,522
-1,766,151
-63% -$147M 0.01% 1116
2024
Q1
$244M Buy
2,789,673
+430,808
+18% +$38.6M 0.02% 594
2023
Q4
$227M Sell
2,358,865
-36,356
-2% -$3.22M 0.03% 574
2023
Q3
$212M Sell
2,395,221
-1,264,919
-35% -$113M 0.03% 563
2023
Q2
$317M Buy
3,660,140
+144,310
+4% +$13.6M 0.04% 445
2023
Q1
$342M Buy
3,515,830
+2,370,416
+207% +$246M 0.04% 442
2022
Q4
$119M Sell
1,145,414
-78,091
-6% -$7.33M 0.01% 807
2022
Q3
$104M Buy
1,223,505
+36,884
+3% +$3.28M 0.01% 833
2022
Q2
$98.3M Sell
1,186,621
-19,926
-2% -$1.59M 0.01% 891
2022
Q1
$93M Sell
1,206,547
-457,333
-27% -$38.3M 0.01% 999
2021
Q4
$147M Sell
1,663,880
-45,515
-3% -$3.76M 0.02% 812
2021
Q3
$132M Sell
1,709,395
-1,346
-0.1% -$106K 0.01% 826
2021
Q2
$143M Sell
1,710,741
-156,578
-8% -$12.4M 0.02% 787
2021
Q1
$141M Buy
1,867,319
+55,035
+3% +$4.5M 0.02% 734
2020
Q4
$159M Sell
1,812,284
-67,622
-4% -$5.36M 0.02% 597
2020
Q3
$143M Sell
1,879,906
-390,420
-17% -$39.5M 0.02% 606
2020
Q2
$280M Buy
2,270,326
+171,745
+8% +$17.1M 0.04% 372
2020
Q1
$177M Buy
2,098,581
+344,893
+20% +$29.7M 0.03% 450
2019
Q4
$148M Buy
1,753,688
+161,678
+10% +$12.2M 0.02% 597
2019
Q3
$107M Sell
1,592,010
-257,231
-14% -$19.8M 0.02% 700
2019
Q2
$158M Sell
1,849,241
-57,983
-3% -$4.96M 0.03% 566
2019
Q1
$169M Buy
1,907,224
+91,217
+5% +$8.45M 0.03% 534
2018
Q4
$155M Sell
1,816,007
-193,342
-10% -$18.4M 0.03% 508
2018
Q3
$195M Sell
2,009,349
-208,879
-9% -$20.8M 0.03% 476
2018
Q2
$209M Buy
2,218,228
+438,967
+25% +$38.4M 0.04% 439
2018
Q1
$144M Buy
1,779,261
+72,922
+4% +$6.26M 0.03% 571
2017
Q4
$152M Sell
1,706,339
-501,215
-23% -$43.6M 0.03% 556
2017
Q3
$205M Buy
2,207,554
+149,107
+7% +$13.2M 0.04% 468
2017
Q2
$187M Buy
2,058,447
+198,573
+11% +$18.1M 0.04% 446
2017
Q1
$163M Buy
1,859,874
+172,225
+10% +$15.3M 0.04% 484
2016
Q4
$140M Buy
1,687,649
+38,362
+2% +$3.3M 0.03% 530
2016
Q3
$153M Buy
1,649,287
+452,382
+38% +$42.6M 0.04% 480
2016
Q2
$93.1M Buy
1,196,905
+158,468
+15% +$13.5M 0.02% 654
2016
Q1
$85.7M Sell
1,038,437
-2,705
-0.3% -$220K 0.02% 675
2015
Q4
$109M Buy
1,041,142
+305,492
+42% +$31.9M 0.03% 600
2015
Q3
$77.5M Buy
735,650
+207,176
+39% +$27.7M 0.02% 765
2015
Q2
$72.3M Sell
528,474
-44,180
-8% -$5.47M 0.03% 700
2015
Q1
$71.4M Buy
572,654
+18,412
+3% +$1.95M 0.03% 656
2014
Q4
$50.1M Sell
554,242
-33,676
-6% -$2.8M 0.02% 845
2014
Q3
$42.4M Sell
587,918
-25,898
-4% -$1.7M 0.02% 929
2014
Q2
$38.2M Buy
613,816
+64,362
+12% +$3.89M 0.01% 973
2014
Q1
$37.5M Buy
549,454
+32,245
+6% +$2.38M 0.02% 912
2013
Q4
$36.4M Buy
517,209
+387,764
+300% +$26.3M 0.02% 924
2013
Q3
$9.34M Sell
129,445
-17,282
-12% -$1.15M ﹤0.01% 1856
2013
Q2
$8.18M Buy
+146,727
New +$9.14M ﹤0.01% 1879

Other funds holding BMRN